In an interview, sleep medicine experts Milena K Pavlova, MD, and Rachel Ziegler, MD, discuss the latest developments in sleep disorder therapies and the existing gaps in sleep medicine.
Only 3% of medical oncologists in the United States are Black.
We interview experts Younghoon Kwon, MD, MS, FACC, and Richard J Castriotta, MD, FCCP, FAASM, about the connections between obstructive sleep apnea-sudden cardiac death.
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Sleep disturbances may affect 40% to 90% of patients with PD, and a 2020 study found that about half of patients with PD had multiple sleep disorders.
Even though it is often thought of as a skin condition, many forms of epidermolysis bullosa are truly multisystem disorders, which makes coordinating the care complex.
Experts discuss how clinicians, healthcare leaders, and payers can prioritize incorporating cardiac rehabilitation as part of the standard of care for patients with heart failure.
To learn more about the potential role of cannabinoids in the management of sleep disorders, we interviewed Aleksandra M. Kwasnik, MD, who recently coauthored a review on the topic.
Clinician competence in treating patients of various racial and ethnic backgrounds and the critical need for greater inclusion of diverse populations in trials investigating the pathophysiology and treatment of AD are underscored.
MeiLan K. Han, MD, and Paul Enright, MD, share their opposing perspectives on the necessity and utility of defining “pre-COPD” in at-risk patients.
